Purchase Agreements in the Life Sciences Tools & Services Industry
134 Contracts & Agreements
- 10x Genomics, Inc. (2 contracts)
- Agilent Technologies Inc (2)
- Alpha Teknova, Inc. (2)
- ARQULE INC (3)
- ARYA Sciences Acquisition Corp III (2)
- Avantor, Inc. (1)
- Berkeley Lights, Inc. (2)
- Bio-Matrix Scientific Group, Inc. (1)
- Bio-Techne (1)
- BIOANALYTICAL SYSTEMS INC (6)
- BioNano Genomics, Inc (5)
- BRUKER CORP (4)
- Cambrex Corporation (1)
- CHAMPIONS ONCOLOGY, INC. (5)
- Charles River Laboratories (3)
- ChromaDex Corp. (12)
- CM Life Sciences II Inc. (5)
- CODEXIS INC (2)
- ECO SCIENCE SOLUTIONS, INC. (2)
- EMMAUS LIFE SCIENCES, INC. (4)
- EVIO, INC. (6)
- FLUIDIGM CORP (2)
- HARVARD BIOSCIENCE INC (4)
- HighCape Capital Acquisition Corp. (3)
- Illumina Inc (1)
- InventaBioTech Inc. (1)
- IsoPlexis Corp (1)
- Luminex Corporation (2)
- Miromatrix Medical Inc. (1)
- NanoString Technologies Inc (3)
- NEOGENOMICS INC (4)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (1)
- PerkinElmer (10)
- Personalis, Inc. (2)
- Pharma-Bio Serv, Inc. (3)
- PRA Health Sciences (1)
- PRESSURE BIOSCIENCES INC (10)
- Repligen Corporation (2)
- SeqLL, Inc. (2)
- Syneos Health (7)
- VG Acquisition Corp. (3)
- Form of Securities Purchase Agreement dated July 4, 2024 between Bionano Genomics, Inc. and the purchasers party thereto (BioNano Genomics, Inc, Filed With SEC on July 8, 2024)
- Securities Purchase Agreement, dated May 24, 2024, by and among the Company and the Buyers named therein (BioNano Genomics, Inc, Filed With SEC on May 28, 2024)
- Asset Purchase Agreement, dated as of April 17, 2024, by and between Bruker Corporation and NanoString Technologies, Inc (BRUKER CORP, Filed With SEC on April 22, 2024)
- Asset Purchase Agreement, dated as of April 17, 2024, by and between NanoString Technologies, Inc. and Bruker Corporation (NanoString Technologies Inc, Filed With SEC on April 19, 2024)
- Form of Securities Purchase Agreement dated April 4, 2024 between Bionano Genomics, Inc. and the purchasers party thereto (BioNano Genomics, Inc, Filed With SEC on April 5, 2024)
- Asset Purchase Agreement, dated as of March 10, 2024, by and between NanoString Technologies, Inc. and Nucleus Buyer, LLC (NanoString Technologies Inc, Filed With SEC on March 12, 2024)
- Asset Purchase Agreement between Pressure BioSciences, Inc. and CBH International LLC, dated January 9, 2024 (PRESSURE BIOSCIENCES INC, Filed With SEC on January 25, 2024)
- Securities Purchase Agreement, dated October 11, 2023, by and among the Company and the Purchaser named therein (BioNano Genomics, Inc, Filed With SEC on October 11, 2023)
- Form of Securities Purchase Agreement, dated September 15, 2023 (PIPE Private Placement) (Alpha Teknova, Inc., Filed With SEC on September 19, 2023)
- Form of Securities Purchase Agreement, dated September 15, 2023 (Registered Direct Offering) (Alpha Teknova, Inc., Filed With SEC on September 19, 2023)
- Asset Purchase Agreement dated as of May 29, 2023 between the Company and SeqLL Omics, Inc (SeqLL, Inc., Filed With SEC on May 31, 2023)
- Purchase Agreement, dated April 13, 2023, by and between Bionano Genomics, Inc. and David Barker (BioNano Genomics, Inc, Filed With SEC on April 14, 2023)
- Amended and Restated Master Purchase and Sale Agreement, dated as of March 11, 2023, by and between PerkinElmer, Inc., PerkinElmer U.S. LLC and PerkinElmer Topco, L.P (PerkinElmer, Filed With SEC on March 16, 2023)
- Form of Securities Purchase Agreement dated as of February 13, 2023 between SeqLL Inc. and the purchasers signatory thereto (SeqLL, Inc., Filed With SEC on February 15, 2023)
- Securities Purchase Agreement, dated as of October 10, 2022, by and between the Company and NHSc (ChromaDex Corp., Filed With SEC on October 11, 2022)
- Securities Purchase Agreement (ChromaDex Corp., Filed With SEC on October 3, 2022)
- Master Purchase and Sale Agreement, dated as of August 1, 2022, by and between PerkinElmer, Inc. and Polaris Purchaser, L.P (PerkinElmer, Filed With SEC on August 5, 2022)
- Amendment No. 1 dated as of December 21, 2021 to the Receivables Purchase Agreement, dated as of March 27, 2020, among Avantor Receivables Funding, LLC, VWR International, LLC,... (Avantor, Inc., Filed With SEC on February 11, 2022)
- Membership Interest Purchase Agreement, dated January 10, 2022, by and among Inotiv, Inc., Inotiv Morrisville, LLC, Integrated Laboratory Systems Holdings, LLC and Integrated... (BIOANALYTICAL SYSTEMS INC, Filed With SEC on January 13, 2022)
- Sixth Amendment to the Purchase and Sale Agreement, dated as of October 13, 2021, among each of the entities listed on the signature pages hereto as an Originator, Syneos Health,... (Syneos Health, Filed With SEC on November 3, 2021)
- Patent Purchase Agreement, dated as of May 12, 2021, by and among QIAGEN Sciences, LLC, QIAGEN GmbH and IsoPlexis Corporation (IsoPlexis Corp, Filed With SEC on July 20, 2021)
- Securities Purchase Agreement, dated as of July 19, 2021, by and between Pacific Biosciences of California, Inc. and each of the Investors (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on July 20, 2021)
- Series C Purchase Agreement, dated May 3, 2021, among the Registrant, Baxter Healthcare Corporation and CareDx, Inc (Miromatrix Medical Inc., Filed With SEC on May 28, 2021)
- Securities Purchase Agreement, dated as of May 4, 2021, among NeoGenomics, Inc. and each purchaser party thereto (NEOGENOMICS INC, Filed With SEC on May 5, 2021)
- Asset Purchase Agreement, dated April 13, 2021, by and among Inotiv, Inc., Inotiv Boulder HTL, LLC, HistoTox Labs, Inc. and the stockholder of HistoTox Labs, Inc (BIOANALYTICAL SYSTEMS INC, Filed With SEC on April 19, 2021)
- Forward Purchase Agreement, dated February 22, 2021, by and between the Company and Corvex Management LP (CM Life Sciences II Inc., Filed With SEC on February 26, 2021)
- Forward Purchase Agreement, dated February 22, 2021, by and between the Company and Casdin Capital, LLC (CM Life Sciences II Inc., Filed With SEC on February 26, 2021)
- Private Placement Warrants Purchase Agreement, dated February 22, 2021, by and among the Company, CMLS Holdings LLC and certain of the Companys directors (and/or entities... (CM Life Sciences II Inc., Filed With SEC on February 26, 2021)
- Purchase and Sale Agreement between Northbrook Commercial Properties, LLC, as Seller, and Luminex Corporation, as Purchaser, dated December 4, 2020 (Luminex Corporation, Filed With SEC on February 26, 2021)
- Fifth Amendment to the Purchase and Sale Agreement, dated as of January 22, 2021, among each of the entities listed on the signature pages hereto as an Originator, Syneos Health,... (Syneos Health, Filed With SEC on February 18, 2021)
- First Amendment to the Purchase and Sale Agreement, dated as of January 2, 2019, among various entities listed on Schedule I thereto, as originators, and Syneos Health, LLC, as... (Syneos Health, Filed With SEC on February 18, 2021)
- Form of Forward Purchase Agreement (CM Life Sciences II Inc., Filed With SEC on February 12, 2021)
- Form of Private Placement Warrants Purchase Agreement between the Registrant and CMLS Holdings II LLC (CM Life Sciences II Inc., Filed With SEC on February 12, 2021)
- Asset Purchase Agreement between Eco Science Solutions and Haiku Holdings, LLC (ECO SCIENCE SOLUTIONS, INC., Filed With SEC on February 4, 2021)
- Amendment to Agreement for Purchase and Sale, dated October 15, 2020, between the Registrant and Equity One (West Coast Portfolio) LLC (10x Genomics, Inc., Filed With SEC on November 12, 2020)
- Second Amendment to the Purchase and Sale Agreement, dated as of July 25, 2019, among inVentiv Commercial Services, LLC, each of the entities listed on the signature pages as an... (Syneos Health, Filed With SEC on October 29, 2020)
- Fourth Amendment to the Purchase and Sale Agreement, dated as of September 25, 2020, among each of the entities listed on the signature pages as a New Originator, each of the... (Syneos Health, Filed With SEC on October 29, 2020)
- Private Placement Warrants Purchase Agreement, dated October 1, 2020, between the Company and the Sponsor (VG Acquisition Corp., Filed With SEC on October 6, 2020)
- Securities Purchase Agreement between Bleecker Street Acquisition Sponsor LLC and the Registrant (as predecessor of VG Acquisition Sponsor LLC) (VG Acquisition Corp., Filed With SEC on September 16, 2020)
- Form of Private Placement Warrants Purchase Agreement among the Registrant and VG Acquisition Sponsor LLC (VG Acquisition Corp., Filed With SEC on September 16, 2020)